N/A
N=156
Comparison of hhCG With hCG+ß in the Early Prediction of Ongoing Pregnancy.
Pregnancy Test
Bottom Line
View on ClinicalTrials.gov: NCT03184519 ↗Enrolled (actual)
156
Serious AEs
0.0%
Results posted
Mar 2020
Primary outcome: Primary: Number of Participants With Early Detection of Pregnancy — 142 Participants — p=0.025
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Pregnancy test (Diagnostic_test)
- Age
- Adult · 18+ yrs
- Sex
- Female
- Sponsor
- Instituto Valenciano de Infertilidad, IVI VALENCIA
- Primary completion
- Aug 2018
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants With Early Detection of Pregnancy |
142 | 0.025 sig |
Summary
Proof of concept study for the prediction of ongoing pregnancy in women undergoing In-Vitro Fertilization (IVF), using hyperglycosylated human chorionic gonadotropin (hhCG), early after In-Vitro Fertilization and fresh Embryo Transfer (IVF-ET).
Eligibility Criteria
Inclusion criteria
- Written informed consent
- Patients undergoing their first or second IVF-ET cycle
- Age 18-45 years
- Use of Ovitrelle for final follicular maturation and luteinization
- Fresh or Frozen day-5 blastocysts transrer (Autologus or Egg donation)
Exclusion criteria
- Gestational surrogacy (patient's eggs used for pregnancy in a surrogate mother)
- Canceled IVF cycles
- GnRH agonist triggering cycles in the case of fresh ET.
Data sourced from ClinicalTrials.gov (NCT03184519). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.